TY  - JOUR
SP  - 215
TI  - Soft Tissue Sarcomas in Cats: A Comparative Review on Injection-Site and Non-Injection-Site Sarcomas
PB  - Scienceline Publication
SN  - 2322-4568
ID  - eprints1538
A1  - Wright, Carolina
A1  - Gustavo Barbeito, Claudio
A1  - Natalia Zanuzzi, Carolina
JF  - World?s Veterinary Journal
AV  - public
UR  - https://wvj.science-line.com/attachments/article/86/WVJ15(2)215-223,2025.pdf
N2  - Malignant tumors originating in connective tissue cells of mesenchymal origin are considered soft tissue sarcomas. Soft tissue sarcomas represent between 7%-9% of malignant tumors of the skin and subcutaneous tissue in cats. Among the sarcomas affecting cats, there is a specific group known as inoculation site-associated sarcomas. Sarcomas that do not occur at sites typically used for the injection of substances will be classified in this review as non-inoculation site-associated sarcomas. Fibrosarcoma is the most common histological type and accounts for 80?92% of soft tissue sarcomas in cats. The prevalence of non-inoculation site sarcomas in cats is 17 in 100,000, while the prevalence of inoculation site sarcomas is estimated to be between 1 in 1,000 and 1 in 10,000 vaccinated cats. The present study aimed to compare the information present in the available literature in relation to the morphological characteristics, biological behavior, pathogenesis, diagnosis, and treatment of both inoculation site-associated and non-associated sarcomas in cats. A more complete understanding of these neoplasms and their differences is essential to deepen the understanding of their genesis and progression. A better understanding could lead to the development of more effective intervention strategies that improve the quality of life and survival of cats affected by these sarcomas.
EP  - 223
VL  - 15
KW  - Feline sarcoma
KW  -  Inoculation site
KW  -  Oncology
KW  -  Soft tissue sarcoma
KW  -  Vaccination
Y1  - 2025/06/25/
IS  - 2
ER  -